AKBA
Price
$2.74
Change
+$0.03 (+1.11%)
Updated
Sep 26 closing price
Capitalization
726.5M
40 days until earnings call
RMTI
Price
$1.27
Change
+$0.05 (+4.10%)
Updated
Sep 26 closing price
Capitalization
43.73M
51 days until earnings call
Interact to see
Advertisement

AKBA vs RMTI

Header iconAKBA vs RMTI Comparison
Open Charts AKBA vs RMTIBanner chart's image
Akebia Therapeutics
Price$2.74
Change+$0.03 (+1.11%)
Volume$1.94M
Capitalization726.5M
Rockwell Medical
Price$1.27
Change+$0.05 (+4.10%)
Volume$697.24K
Capitalization43.73M
AKBA vs RMTI Comparison Chart in %
Loading...
AKBA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RMTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AKBA vs. RMTI commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKBA is a Hold and RMTI is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 28, 2025
Stock price -- (AKBA: $2.74 vs. RMTI: $1.27)
Brand notoriety: AKBA and RMTI are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AKBA: 50% vs. RMTI: 41%
Market capitalization -- AKBA: $726.5M vs. RMTI: $43.73M
AKBA [@Pharmaceuticals: Generic] is valued at $726.5M. RMTI’s [@Pharmaceuticals: Generic] market capitalization is $43.73M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.83B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKBA’s FA Score shows that 0 FA rating(s) are green whileRMTI’s FA Score has 0 green FA rating(s).

  • AKBA’s FA Score: 0 green, 5 red.
  • RMTI’s FA Score: 0 green, 5 red.
According to our system of comparison, RMTI is a better buy in the long-term than AKBA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AKBA’s TA Score shows that 3 TA indicator(s) are bullish while RMTI’s TA Score has 4 bullish TA indicator(s).

  • AKBA’s TA Score: 3 bullish, 4 bearish.
  • RMTI’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both AKBA and RMTI are a bad buy in the short-term.

Price Growth

AKBA (@Pharmaceuticals: Generic) experienced а -2.84% price change this week, while RMTI (@Pharmaceuticals: Generic) price change was -4.51% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.16%. For the same industry, the average monthly price growth was +24.25%, and the average quarterly price growth was +66.99%.

Reported Earning Dates

AKBA is expected to report earnings on Nov 06, 2025.

RMTI is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.16% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AKBA($726M) has a higher market cap than RMTI($43.7M). AKBA YTD gains are higher at: 44.211 vs. RMTI (-37.745). AKBA has higher annual earnings (EBITDA): 11M vs. RMTI (1.23M). AKBA has more cash in the bank: 137M vs. RMTI (18.4M). RMTI has less debt than AKBA: RMTI (14M) vs AKBA (53.4M). AKBA has higher revenues than RMTI: AKBA (204M) vs RMTI (88M).
AKBARMTIAKBA / RMTI
Capitalization726M43.7M1,661%
EBITDA11M1.23M892%
Gain YTD44.211-37.745-117%
P/E RatioN/AN/A-
Revenue204M88M232%
Total Cash137M18.4M745%
Total Debt53.4M14M381%
FUNDAMENTALS RATINGS
AKBA vs RMTI: Fundamental Ratings
AKBA
RMTI
OUTLOOK RATING
1..100
5568
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
45
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10095
PRICE GROWTH RATING
1..100
4951
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5090

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RMTI's Valuation (45) in the Medical Specialties industry is in the same range as AKBA (76) in the Biotechnology industry. This means that RMTI’s stock grew similarly to AKBA’s over the last 12 months.

RMTI's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as AKBA (100) in the Biotechnology industry. This means that RMTI’s stock grew similarly to AKBA’s over the last 12 months.

RMTI's SMR Rating (95) in the Medical Specialties industry is in the same range as AKBA (100) in the Biotechnology industry. This means that RMTI’s stock grew similarly to AKBA’s over the last 12 months.

AKBA's Price Growth Rating (49) in the Biotechnology industry is in the same range as RMTI (51) in the Medical Specialties industry. This means that AKBA’s stock grew similarly to RMTI’s over the last 12 months.

AKBA's P/E Growth Rating (100) in the Biotechnology industry is in the same range as RMTI (100) in the Medical Specialties industry. This means that AKBA’s stock grew similarly to RMTI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AKBARMTI
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
87%
Momentum
ODDS (%)
Bearish Trend 3 days ago
74%
Bearish Trend 3 days ago
85%
MACD
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
89%
Advances
ODDS (%)
Bullish Trend about 1 month ago
86%
Bullish Trend 13 days ago
86%
Declines
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 6 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
79%
Aroon
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
AKBA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RMTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLIR0.810.08
+10.24%
ClearSign Technologies Corp
ASTH29.681.80
+6.46%
Astrana Health
SCPH5.650.04
+0.71%
scPharmaceuticals
DIS113.470.48
+0.42%
Walt Disney Company (The)
KMX44.86-0.74
-1.62%
CarMax

AKBA and

Correlation & Price change

A.I.dvisor indicates that over the last year, AKBA has been loosely correlated with IPSC. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if AKBA jumps, then IPSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKBA
1D Price
Change %
AKBA100%
+1.11%
IPSC - AKBA
39%
Loosely correlated
+4.39%
XERS - AKBA
39%
Loosely correlated
+4.20%
SYRE - AKBA
37%
Loosely correlated
+4.04%
KYMR - AKBA
36%
Loosely correlated
+4.68%
RXRX - AKBA
35%
Loosely correlated
+1.94%
More

RMTI and

Correlation & Price change

A.I.dvisor indicates that over the last year, RMTI has been loosely correlated with AVDL. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if RMTI jumps, then AVDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RMTI
1D Price
Change %
RMTI100%
+4.10%
AVDL - RMTI
33%
Loosely correlated
+0.07%
EBS - RMTI
30%
Poorly correlated
+1.95%
EVOK - RMTI
28%
Poorly correlated
-2.20%
HROW - RMTI
28%
Poorly correlated
+2.06%
AKBA - RMTI
26%
Poorly correlated
+1.11%
More